Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameh Saber

Showing results (71-80 of 136) with videos related to

Pageof 14
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 20, 2022
Combining the HSP90 inhibitor TAS-116 with metformin effectively degrades the NLRP3 and attenuates inflammasome activation in rats: A new management paradigm for ulcerative colitisAhmed A Shaaban, Amir Mohamed Abdelhamid, Mohamed E Shaker, et al.
Tissue & Cell|June 3, 2026
Lactose-decorated, alginate-coated chitosan nanoparticles loaded with Coomassie Brilliant Blue G-250 protect colonic barrier integrity in experimental colitisMaha M Amer, Ahmed Y Kira, Sameh Saber, et al.
Life Sciences|October 24, 2021
Blunting p38 MAPKα and ERK1/2 activities by empagliflozin enhances the antifibrotic effect of metformin and augments its AMPK-induced NF-κB inactivation in mice intoxicated with carbon tetrachlorideAmir Mohamed Abdelhamid, Mahmoud E Youssef, Eslam E Abd El-Fattah, et al.
Frontiers in Pharmacology|October 3, 2024
Activation of AMPK/SIRT1/FOXO3a signaling by BMS-477118 (saxagliptin) mitigates chronic colitis in rats: uncovering new anti-inflammatory and antifibrotic rolesElsayed A Elmorsy, Mahmoud E Youssef, Mohamed R Abdel-Hamed, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 3, 2025
Diabetic retinopathy in focus: Update on treatment advances, pharmaceutical approaches, and new technologiesAdela Laura Ciorba, Sameh Saber, Amir Mohamed Abdelhamid, et al.
Journal of Inflammation Research|July 29, 2021
The Supportive Role of NSC328382, a P2X7R Antagonist, in Enhancing the Inhibitory Effect of CRID3 on NLRP3 Inflammasome Activation in Rats with Dextran Sodium Sulfate-Induced ColitisSameh Saber, Galal Yahya, Naglaa A Gobba, et al.
Tissue & Cell|February 11, 2026
FOXO3a-mediated structural and cellular remodeling in liver tissue: Implications for apoptosis and homeostasisHeba Ibrahim Abd El-Moaty, Sameh Saber, Rabab S Hamad, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 12, 2025
Modulation of FOXO3a Nuclear Localization by Linagliptin (BI-1356) reveals a new therapeutic target in chronic ulcerative colitisAbdulaziz Saad Alshahrani, Sameh Saber, Ohoud Shafi Alruwaili, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
(R,R)-BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and PyroptosisSameh Saber, Mohannad Mohammad S Alamri, Jaber Alfaifi, et al.
Tissue & Cell|June 1, 2026
Engineering stem cell morphology and tissue architecture through nano-engineered materialsRabab S Hamad, Sameh Saber, Elsayed A Elmorsy, et al.
Pageof 14

Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 20, 2022
Combining the HSP90 inhibitor TAS-116 with metformin effectively degrades the NLRP3 and attenuates inflammasome activation in rats: A new management paradigm for ulcerative colitisAhmed A Shaaban, Amir Mohamed Abdelhamid, Mohamed E Shaker, et al.
Tissue & Cell|June 3, 2026
Lactose-decorated, alginate-coated chitosan nanoparticles loaded with Coomassie Brilliant Blue G-250 protect colonic barrier integrity in experimental colitisMaha M Amer, Ahmed Y Kira, Sameh Saber, et al.
Life Sciences|October 24, 2021
Blunting p38 MAPKα and ERK1/2 activities by empagliflozin enhances the antifibrotic effect of metformin and augments its AMPK-induced NF-κB inactivation in mice intoxicated with carbon tetrachlorideAmir Mohamed Abdelhamid, Mahmoud E Youssef, Eslam E Abd El-Fattah, et al.
Frontiers in Pharmacology|October 3, 2024
Activation of AMPK/SIRT1/FOXO3a signaling by BMS-477118 (saxagliptin) mitigates chronic colitis in rats: uncovering new anti-inflammatory and antifibrotic rolesElsayed A Elmorsy, Mahmoud E Youssef, Mohamed R Abdel-Hamed, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 3, 2025
Diabetic retinopathy in focus: Update on treatment advances, pharmaceutical approaches, and new technologiesAdela Laura Ciorba, Sameh Saber, Amir Mohamed Abdelhamid, et al.
Journal of Inflammation Research|July 29, 2021
The Supportive Role of NSC328382, a P2X7R Antagonist, in Enhancing the Inhibitory Effect of CRID3 on NLRP3 Inflammasome Activation in Rats with Dextran Sodium Sulfate-Induced ColitisSameh Saber, Galal Yahya, Naglaa A Gobba, et al.
Tissue & Cell|February 11, 2026
FOXO3a-mediated structural and cellular remodeling in liver tissue: Implications for apoptosis and homeostasisHeba Ibrahim Abd El-Moaty, Sameh Saber, Rabab S Hamad, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 12, 2025
Modulation of FOXO3a Nuclear Localization by Linagliptin (BI-1356) reveals a new therapeutic target in chronic ulcerative colitisAbdulaziz Saad Alshahrani, Sameh Saber, Ohoud Shafi Alruwaili, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
(R,R)-BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and PyroptosisSameh Saber, Mohannad Mohammad S Alamri, Jaber Alfaifi, et al.
Tissue & Cell|June 1, 2026
Engineering stem cell morphology and tissue architecture through nano-engineered materialsRabab S Hamad, Sameh Saber, Elsayed A Elmorsy, et al.
Pageof 14